PT103177A - 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos - Google Patents

1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos

Info

Publication number
PT103177A
PT103177A PT103177A PT10317704A PT103177A PT 103177 A PT103177 A PT 103177A PT 103177 A PT103177 A PT 103177A PT 10317704 A PT10317704 A PT 10317704A PT 103177 A PT103177 A PT 103177A
Authority
PT
Portugal
Prior art keywords
colecalciferol
epi
homo
diene
medicines
Prior art date
Application number
PT103177A
Other languages
English (en)
Inventor
Adorini Luciano
Colli Enrico
Original Assignee
Bioxell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0322395A external-priority patent/GB0322395D0/en
Priority claimed from GB0325598A external-priority patent/GB2407499B/en
Application filed by Bioxell Spa filed Critical Bioxell Spa
Publication of PT103177A publication Critical patent/PT103177A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT103177A 2003-09-24 2004-07-29 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos PT103177A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0322395A GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions
GB0325598A GB2407499B (en) 2003-11-03 2003-11-03 Vitamin D3 analogue for use in the treatment of BPH

Publications (1)

Publication Number Publication Date
PT103177A true PT103177A (pt) 2005-03-31

Family

ID=34315450

Family Applications (1)

Application Number Title Priority Date Filing Date
PT103177A PT103177A (pt) 2003-09-24 2004-07-29 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos

Country Status (5)

Country Link
US (2) US7332482B2 (pt)
AU (2) AU2004203436A1 (pt)
CA (1) CA2476224A1 (pt)
PT (1) PT103177A (pt)
SG (1) SG110107A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005249494A1 (en) * 2004-05-28 2005-12-15 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
WO2006099121A2 (en) * 2005-03-10 2006-09-21 Elan Pharma International Limited Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
US20080242717A1 (en) * 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia
US8154421B2 (en) * 2009-05-12 2012-04-10 Fisher Clinical Services Inc. Real time temperature and location tracker
JP5836373B2 (ja) 2010-07-15 2015-12-24 ヒブリジェニクス・エスアー ビタミンｄの１４−エピ−アナログの新しい製剤
EP2407152A1 (en) 2010-07-15 2012-01-18 Hybrigenics S.A. Formulations of 14-epi-analogues of vitamin D
EP3053598A1 (en) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol soft capsules

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5428029A (en) 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
TW403735B (en) * 1995-11-22 2000-09-01 Hoffmann La Roche 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol
US5747479A (en) * 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
SG70009A1 (en) 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
SG70010A1 (en) 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
US5939408A (en) * 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
WO1998049138A2 (en) 1997-04-28 1998-11-05 F.Hoffmann-La Roche Ag Vitamin d3 analogs with bis c-20 side chains
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US5811414A (en) * 1997-05-16 1998-09-22 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
IT1297381B1 (it) 1997-12-09 1999-09-01 Mario Serio Uso di analoghi della vitamina d3 come inibitori della proliferazione di cellule ipertrofiche di prostata umana
US5972917A (en) 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
US6603030B1 (en) 1999-04-22 2003-08-05 Hoffman-La Roche Inc. Process for producing phosphineoxide vitamin D precursors
US6255501B1 (en) 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
WO2001030751A2 (en) 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
MXPA04003405A (es) 2001-10-10 2004-06-18 Pharmacia Italia Spa Metodos para prevenir y tratar la perdida de hueso con compuestos esteroidales.
WO2003034961A1 (en) 2001-10-23 2003-05-01 Euro-Celtique, S.A. Terazosin transdermal device and methods
IL162213A0 (en) 2001-12-03 2005-11-20 Novacea Inc Pharmaceutical compositions containing active vitamin d compounds

Also Published As

Publication number Publication date
SG110107A1 (en) 2005-04-28
AU2008203397A1 (en) 2008-08-21
US20050065124A1 (en) 2005-03-24
CA2476224A1 (en) 2005-03-24
US20080207769A1 (en) 2008-08-28
US7332482B2 (en) 2008-02-19
AU2004203436A1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
CY2018009I2 (el) Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων
DE602004000683D1 (de) Fingerabdrucksensor und dessen Herstellungsverfahren
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
CY2012024I1 (el) Υπο-ακετυλιωμενα και υπερ-ακετυλιωμενα μηνιγγοκοκκικα καψικα σακχαριδια
DK1620118T3 (da) Reversible pegylerede lægemidler
CY2011003I2 (el) Φαρμακευτικα προϊοντα σε διαλυμα που περιεχουν αντισωμα
IS7894A (is) Skammtaform með ofnæmisvaka
PT1419150E (pt) Derivados de 1-fenilsulfonil-1,3-di-hidro-2h-indol-2-ona, sua preparacao e sua aplicacao em terapeutica
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
BR0300396B1 (pt) artigo absorvente higiÊnico.
EE200300485A (et) Tiohüdantoinid ja nende kasutamine diabeedi raviks
DK1603565T3 (da) Medikament omfattende en höjaktiv længevarende beta2-agonisk i kombination med andre aktive ingredienser
DK1773796T3 (da) Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
BR0208969B1 (pt) produto absorvente com ajuste melhorado.
PT1513836E (pt) Derivados de piperazinilacilpiperidina, sua preparacao e sua aplicacao em terapeutica
ITRM20030204A0 (it) Formulazione dermatologica.
DE602004016599D1 (de) Abweichungsdetektionsvorrichtung und informationsgerät mit verwendung derselben
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
PT103177A (pt) 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos
DE602004030564D1 (de) 2-substituierte phenyl-5,7-dialkyl-3,7-dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung
SE0203313L (sv) Behållare med syrabarriär och användning därav
ITMI20031806A1 (it) Argille organofiliche e loro impiego nella preparazione di materiali nanocompositi.
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.

Legal Events

Date Code Title Description
BB1A Laying open of patent application
MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20110131